RESEARCH STARTER

Artificial Insemination

Artificial insemination (AI) is a reproductive procedure that involves placing sperm inside the reproductive system of a female without sexual contact. This technique is widely used in animal breeding to manage the genetic traits of offspring and enhance reproduction rates. In humans, artificial insemination serves as a solution for couples facing challenges with natural conception. The practice has roots in the 18th century, with early attempts leading to significant developments in both animal and human applications over the years.

Advancements in technology have allowed for improved success rates, with techniques evolving from simple placement of sperm to more refined methods such as intrauterine insemination (IUI). However, the practice is accompanied by ethical considerations, particularly regarding the use of donor sperm, questions of parentage, and implications for family dynamics. Additionally, cultural and religious views on artificial insemination vary, with some groups expressing opposition to certain methods. Overall, artificial insemination offers a pathway for many individuals and couples to achieve their desired family structures while also supporting animal breeding and conservation efforts.

Full Article

Artificial insemination is a procedure to place sperm from a male organism inside the reproductive system of a female organism without sexual contact. Animal breeders use artificial insemination to control the genetic makeup of animal offspring and promote reproduction. Human artificial insemination is generally used in cases where successful conception through natural means is not possible.

The technology for artificial insemination in animals was first practiced in the eighteenth century. Human artificial insemination was also first attempted in the eighteenth century but was not commonly used until the twentieth century. The technology used for all forms of artificial insemination has improved, and new techniques have been developed; however, the procedure has also raised a number of ethical and practical concerns for medical professionals and those involved in the process.

History

Dutch scientist Antonie van Leeuwenhoek and his assistant Johan Hamm discovered the existence of sperm in 1678 while examining a semen sample under a microscope. The presence of ova in the female body was recognized in 1827, and in 1843 scientists determined that conception occurred when sperm entered an ovum and began cell division through mitosis.

Building on this early research and work of his own in animal reproduction, Italian biologist Lazzaro Spallanzani successfully inseminated a dog through artificial means in 1784, following earlier experiments in the 1780s. The procedure resulted in the birth of three puppies. Near the end of the nineteenth century, a number of Russian researchers were developing techniques for animal insemination. This work and similar undertakings by scientists in Japan and Denmark focused on livestock animals such as cattle, horses, and pigs. As techniques improved to make the process more effective, interest in the technology grew until it became a common practice in animal husbandry.

The earliest known attempt at human artificial insemination was recorded by a Scottish surgeon in 1790. John Hunter instructed his patient, who had a birth defect that prevented insemination through sexual intercourse, to collect his semen and inject it inside his partner’s vagina with a syringe. The procedure resulted in a successful pregnancy. Experiments in human insemination followed in England, France, Germany, and the United States. By the middle of the twentieth century, researchers had improved the techniques and added advances such as freezing sperm for later use. In 1953, doctors reported the first human pregnancy achieved with frozen sperm. Later work improved sperm freezing by using protective substances such as glycerol and by storing samples in sperm banks. By the mid-twentieth century, artificial insemination had already become common, and in the twenty-first century it was widely used as an approach for treating infertility from a variety of causes.

Techniques

For most of the first hundred years of its use, artificial insemination remained similar to what Hunter had suggested to his patient: a semen sample was collected from the male partner and then deposited high inside the female partner’s vagina by the physician. This is known as intravaginal insemination. In the middle of the twentieth century, a variation of the technique was developed that used a cervical cap—a small, rubber cuplike device—that could be filled with sperm and placed at the cervix, or entrance to the uterus, to keep the sperm in place. This improved the success rate, as did intracervical insemination, or placing the semen sample into the cervix.

Around the 1960s, techniques were developed to refine the semen sample so that it contained a higher concentration of motile sperm. This enriched sample was then placed directly into the woman's uterus in a variation of artificial insemination known as intrauterine insemination, or IUI. Doctors may combine IUI with medicines that stimulate ovulation. IUI may also be used before moving to other fertility treatments, such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

The success of artificial insemination in humans depends on a number of factors, including the condition of the female partner’s reproductive system and the health and mobility of the sperm. When donor sperm is used, clinics also screen donors for infectious diseases and review genetic risk. It is also crucial to synchronize the efforts with the woman's natural reproductive cycle.

A different technique, post-cervical artificial insemination (PCAI), deposits semen beyond the cervix and is increasingly common in animal husbandry.

Ethical Concerns

William Pancoast, a doctor practicing in Philadelphia, is credited with the first successful artificial insemination in a human using donor sperm in 1884, but he did so through questionable means. Pancoast's examination of the male half of the infertile couple determined that the man produced no live sperm. Rather than telling the couple this, Pancoast swore his medical students to secrecy and had one of them provide a semen sample, which Pancoast used to inseminate the woman. She successfully conceived and delivered a son. Pancoast subsequently told the husband but not the wife about the source of the sperm.

This was one of the earliest documented cases in which donor sperm was used to impregnate a woman through artificial insemination. The use of donor sperm raises concerns for many people about the possibility of wholesale efforts to control the human race through genetic engineering. Concerns also arise over the parentage of children conceived through the use of donor sperm, with issues including custody disputes and child support. The development of techniques that allow for sperm to be frozen for later use has brought to light questions of who the sperm belongs to if the couple divorces. Laws also differ on donor records, legal parentage, and who may receive treatment. These differences have led some patients to seek reproductive care in other states or countries.

The ability to create a child without the need for sexual intercourse between partners has also raised issues about single women or same-sex couples seeking to use artificial insemination to have a child. Some religious groups oppose all human artificial insemination, while others do not object to inseminating a partner with a spouse’s sperm but oppose other forms of insemination involving a donor.

Benefits

Artificial insemination makes it possible for couples having trouble conceiving through sexual intercourse to have a child that shares the genetic makeup of at least one parent and often both parents.

In the animal kingdom, artificial insemination makes it possible to breed for the most desirable characteristics, allowing for healthier, stronger animals. It can also help to sustain species that are endangered in the wild by allowing them to be bred and raised in controlled, protected environments. Zoos and conservation programs also use artificial insemination to help manage genetic diversity in rare and endangered animals.


Bibliography

American Society for Reproductive Medicine. “Interests, Obligations, and Rights in Gamete and Embryo Donation: An Ethics Committee Opinion.” Fertility and Sterility, vol. 111, no. 4, 2019, pp. 664–70, doi:10.1016/j.fertnstert.2019.01.018. Accessed 26 Mar. 2026.

American Society for Reproductive Medicine. “Updated Terminology for Gamete and Embryo Donors: Directed (Identified) to Replace ‘Known’ and Nonidentified to Replace Anonymous: A Committee Opinion.” Fertility and Sterility, vol. 118, no. 1, 2022, pp. 75–8, www.fertstert.org/article/S0015-0282(22)00151-0/fulltext. Accessed 26 Mar. 2026.

Anger, Jennifer T., et al. “Cryopreservation of Sperm: Indications, Methods and Results.” The Journal of Urology, vol. 170, no. 4, pt. 1, 2003, pp. 1079–84, doi:10.1097/01.ju.0000084820.98430.b8. Accessed 26 Mar. 2026.

Blanco, José M., et al. “Implementing Artificial Insemination as an Effective Tool for Ex Situ Conservation of Endangered Avian Species.” Theriogenology, vol. 71, no. 1, 2009, pp. 200–13, doi:10.1016/j.theriogenology.2008.09.019. Accessed 26 Mar. 2026.

Foote, R. H. "The History of Artificial Insemination: Selected Notes and Notables." American Society of Animal Science. www.asas.org/docs/publications/footehist.pdf. Accessed 26 Mar. 2026.

“Infertility and Artificial Insemination.” WebMD, 9 Nov. 2024, www.webmd.com/infertility-and-reproduction/artificial-insemination. Accessed 26 Mar. 2026.

Ombelet, W., and J. Van Robays. "Artificial Insemination History: Hurdles and Milestones." Facts, Views & Vision in ObGyn, vol. 7, no. 2, 2015, pp. 137–43. www.ncbi.nlm.nih.gov/pmc/articles/PMC4498171/. Accessed 26 Mar. 2026.

The Practice Committee of the American Society for Reproductive Medicine. “Evidence-Based Treatments for Couples with Unexplained Infertility: A Guideline.” Fertility and Sterility, vol. 113, no. 2, 2020, pp. 305–22, doi:10.1016/j.fertnstert.2019.10.014. Accessed 26 Mar. 2026.

The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technology. “Gamete and Embryo Donation Guidance.” Fertility and Sterility, vol. 122, no. 5, 2024, pp. 799–813, doi:10.1016/j.fertnstert.2024.06.004. Accessed 26 Mar. 2026.

Schlegel, Peter N., et al. “Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part II.” Fertility and Sterility, American Society for Reproductive Medicine, 2021. www.asrm.org/practice-guidance/practice-committee-documents/diagnosis-and-treatment-of-infertility-in-men-aua-asrm-guideline-part2/. Accessed 26 Mar. 2026.

Simopoulou, Mara, et al. “Treating Infertility: Current Affairs of Cross-Border Reproductive Care.” Open Medicine, vol. 14, no. 1, 12 Mar. 2019, pp. 292–99, doi:10.1515/med-2019-0026. Accessed 26 Mar. 2026.

Suárez-Usbeck, Andrés, et al. "Post-Cervical Compared with Cervical Insemination in Gilts: Reproductive Variable Assessments." Animal Reproduction Science, vol. 211, 2019, article 106207. doi:10.1016/j.anireprosci.2019.106207. Accessed 26 Mar. 2026.

“Testing Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) Donors for Relevant Communicable Disease Agents and Diseases.” Food and Drug Administration, 4 Nov. 2024, www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/testing-human-cells-tissues-and-cellular-and-tissue-based-product-hctp-donors-relevant-communicable. Accessed 26 Mar. 2026.

“What You Should Know—Reproductive Tissue Donation.” Food and Drug Administration, 25 Apr. 2019. www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/what-you-should-know-reproductive-tissue-donation. Accessed 26 Mar. 2026.

Yuko, Elizabeth. “The First Artificial Insemination Was an Ethical Nightmare.” The Atlantic. 8 Jan. 2016. www.theatlantic.com/health/archive/2016/01/first-artificial-insemination/423198/. Accessed 26 Mar. 2026.

Full Article

Artificial insemination is a procedure to place sperm from a male organism inside the reproductive system of a female organism without sexual contact. Animal breeders use artificial insemination to control the genetic makeup of animal offspring and promote reproduction. Human artificial insemination is generally used in cases where successful conception through natural means is not possible.

The technology for artificial insemination in animals was first practiced in the eighteenth century. Human artificial insemination was also first attempted in the eighteenth century but was not commonly used until the twentieth century. The technology used for all forms of artificial insemination has improved, and new techniques have been developed; however, the procedure has also raised a number of ethical and practical concerns for medical professionals and those involved in the process.

History

Dutch scientist Antonie van Leeuwenhoek and his assistant Johan Hamm discovered the existence of sperm in 1678 while examining a semen sample under a microscope. The presence of ova in the female body was recognized in 1827, and in 1843 scientists determined that conception occurred when sperm entered an ovum and began cell division through mitosis.

Building on this early research and work of his own in animal reproduction, Italian biologist Lazzaro Spallanzani successfully inseminated a dog through artificial means in 1784, following earlier experiments in the 1780s. The procedure resulted in the birth of three puppies. Near the end of the nineteenth century, a number of Russian researchers were developing techniques for animal insemination. This work and similar undertakings by scientists in Japan and Denmark focused on livestock animals such as cattle, horses, and pigs. As techniques improved to make the process more effective, interest in the technology grew until it became a common practice in animal husbandry.

The earliest known attempt at human artificial insemination was recorded by a Scottish surgeon in 1790. John Hunter instructed his patient, who had a birth defect that prevented insemination through sexual intercourse, to collect his semen and inject it inside his partner’s vagina with a syringe. The procedure resulted in a successful pregnancy. Experiments in human insemination followed in England, France, Germany, and the United States. By the middle of the twentieth century, researchers had improved the techniques and added advances such as freezing sperm for later use. In 1953, doctors reported the first human pregnancy achieved with frozen sperm. Later work improved sperm freezing by using protective substances such as glycerol and by storing samples in sperm banks. By the mid-twentieth century, artificial insemination had already become common, and in the twenty-first century it was widely used as an approach for treating infertility from a variety of causes.

Techniques

For most of the first hundred years of its use, artificial insemination remained similar to what Hunter had suggested to his patient: a semen sample was collected from the male partner and then deposited high inside the female partner’s vagina by the physician. This is known as intravaginal insemination. In the middle of the twentieth century, a variation of the technique was developed that used a cervical cap—a small, rubber cuplike device—that could be filled with sperm and placed at the cervix, or entrance to the uterus, to keep the sperm in place. This improved the success rate, as did intracervical insemination, or placing the semen sample into the cervix.

Around the 1960s, techniques were developed to refine the semen sample so that it contained a higher concentration of motile sperm. This enriched sample was then placed directly into the woman's uterus in a variation of artificial insemination known as intrauterine insemination, or IUI. Doctors may combine IUI with medicines that stimulate ovulation. IUI may also be used before moving to other fertility treatments, such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

The success of artificial insemination in humans depends on a number of factors, including the condition of the female partner’s reproductive system and the health and mobility of the sperm. When donor sperm is used, clinics also screen donors for infectious diseases and review genetic risk. It is also crucial to synchronize the efforts with the woman's natural reproductive cycle.

A different technique, post-cervical artificial insemination (PCAI), deposits semen beyond the cervix and is increasingly common in animal husbandry.

Ethical Concerns

William Pancoast, a doctor practicing in Philadelphia, is credited with the first successful artificial insemination in a human using donor sperm in 1884, but he did so through questionable means. Pancoast's examination of the male half of the infertile couple determined that the man produced no live sperm. Rather than telling the couple this, Pancoast swore his medical students to secrecy and had one of them provide a semen sample, which Pancoast used to inseminate the woman. She successfully conceived and delivered a son. Pancoast subsequently told the husband but not the wife about the source of the sperm.

This was one of the earliest documented cases in which donor sperm was used to impregnate a woman through artificial insemination. The use of donor sperm raises concerns for many people about the possibility of wholesale efforts to control the human race through genetic engineering. Concerns also arise over the parentage of children conceived through the use of donor sperm, with issues including custody disputes and child support. The development of techniques that allow for sperm to be frozen for later use has brought to light questions of who the sperm belongs to if the couple divorces. Laws also differ on donor records, legal parentage, and who may receive treatment. These differences have led some patients to seek reproductive care in other states or countries.

The ability to create a child without the need for sexual intercourse between partners has also raised issues about single women or same-sex couples seeking to use artificial insemination to have a child. Some religious groups oppose all human artificial insemination, while others do not object to inseminating a partner with a spouse’s sperm but oppose other forms of insemination involving a donor.

Benefits

Artificial insemination makes it possible for couples having trouble conceiving through sexual intercourse to have a child that shares the genetic makeup of at least one parent and often both parents.

In the animal kingdom, artificial insemination makes it possible to breed for the most desirable characteristics, allowing for healthier, stronger animals. It can also help to sustain species that are endangered in the wild by allowing them to be bred and raised in controlled, protected environments. Zoos and conservation programs also use artificial insemination to help manage genetic diversity in rare and endangered animals.


Bibliography

American Society for Reproductive Medicine. “Interests, Obligations, and Rights in Gamete and Embryo Donation: An Ethics Committee Opinion.” Fertility and Sterility, vol. 111, no. 4, 2019, pp. 664–70, doi:10.1016/j.fertnstert.2019.01.018. Accessed 26 Mar. 2026.

American Society for Reproductive Medicine. “Updated Terminology for Gamete and Embryo Donors: Directed (Identified) to Replace ‘Known’ and Nonidentified to Replace Anonymous: A Committee Opinion.” Fertility and Sterility, vol. 118, no. 1, 2022, pp. 75–8, www.fertstert.org/article/S0015-0282(22)00151-0/fulltext. Accessed 26 Mar. 2026.

Anger, Jennifer T., et al. “Cryopreservation of Sperm: Indications, Methods and Results.” The Journal of Urology, vol. 170, no. 4, pt. 1, 2003, pp. 1079–84, doi:10.1097/01.ju.0000084820.98430.b8. Accessed 26 Mar. 2026.

Blanco, José M., et al. “Implementing Artificial Insemination as an Effective Tool for Ex Situ Conservation of Endangered Avian Species.” Theriogenology, vol. 71, no. 1, 2009, pp. 200–13, doi:10.1016/j.theriogenology.2008.09.019. Accessed 26 Mar. 2026.

Foote, R. H. "The History of Artificial Insemination: Selected Notes and Notables." American Society of Animal Science. www.asas.org/docs/publications/footehist.pdf. Accessed 26 Mar. 2026.

“Infertility and Artificial Insemination.” WebMD, 9 Nov. 2024, www.webmd.com/infertility-and-reproduction/artificial-insemination. Accessed 26 Mar. 2026.

Ombelet, W., and J. Van Robays. "Artificial Insemination History: Hurdles and Milestones." Facts, Views & Vision in ObGyn, vol. 7, no. 2, 2015, pp. 137–43. www.ncbi.nlm.nih.gov/pmc/articles/PMC4498171/. Accessed 26 Mar. 2026.

The Practice Committee of the American Society for Reproductive Medicine. “Evidence-Based Treatments for Couples with Unexplained Infertility: A Guideline.” Fertility and Sterility, vol. 113, no. 2, 2020, pp. 305–22, doi:10.1016/j.fertnstert.2019.10.014. Accessed 26 Mar. 2026.

The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technology. “Gamete and Embryo Donation Guidance.” Fertility and Sterility, vol. 122, no. 5, 2024, pp. 799–813, doi:10.1016/j.fertnstert.2024.06.004. Accessed 26 Mar. 2026.

Schlegel, Peter N., et al. “Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part II.” Fertility and Sterility, American Society for Reproductive Medicine, 2021. www.asrm.org/practice-guidance/practice-committee-documents/diagnosis-and-treatment-of-infertility-in-men-aua-asrm-guideline-part2/. Accessed 26 Mar. 2026.

Simopoulou, Mara, et al. “Treating Infertility: Current Affairs of Cross-Border Reproductive Care.” Open Medicine, vol. 14, no. 1, 12 Mar. 2019, pp. 292–99, doi:10.1515/med-2019-0026. Accessed 26 Mar. 2026.

Suárez-Usbeck, Andrés, et al. "Post-Cervical Compared with Cervical Insemination in Gilts: Reproductive Variable Assessments." Animal Reproduction Science, vol. 211, 2019, article 106207. doi:10.1016/j.anireprosci.2019.106207. Accessed 26 Mar. 2026.

“Testing Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) Donors for Relevant Communicable Disease Agents and Diseases.” Food and Drug Administration, 4 Nov. 2024, www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/testing-human-cells-tissues-and-cellular-and-tissue-based-product-hctp-donors-relevant-communicable. Accessed 26 Mar. 2026.

“What You Should Know—Reproductive Tissue Donation.” Food and Drug Administration, 25 Apr. 2019. www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/what-you-should-know-reproductive-tissue-donation. Accessed 26 Mar. 2026.

Yuko, Elizabeth. “The First Artificial Insemination Was an Ethical Nightmare.” The Atlantic. 8 Jan. 2016. www.theatlantic.com/health/archive/2016/01/first-artificial-insemination/423198/. Accessed 26 Mar. 2026.

More Like ThisRelated Articles

Related Articles (5)

Related Articles (5)